Dasatinib discontinuation in patients (pts) with chronic-phase chronic myeloid leukemia (CML-CP) and stable deep molecular response (DASFREE) Meeting Abstract
| Authors: | Shah, N. P.; Gutiérrez, J. V. G.; Jiménez-Velasco, A.; Larson, S. M.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M.; Gómez-Casares, M. T.; Pane, F.; Nicolini, F. E.; Mauro, M. J.; Sy, O.; Martin-Regueira, P.; Lipton, J. H. |
| Abstract Title: | Dasatinib discontinuation in patients (pts) with chronic-phase chronic myeloid leukemia (CML-CP) and stable deep molecular response (DASFREE) |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419400369 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.314.314 |
| Notes: | Meeting Abstract: 314 -- Source: Wos |
